Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study 2024-11-19 20:30
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe 2024-11-11 20:30
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
1